Skip to main content
Drug Design, Development and Therapy logoLink to Drug Design, Development and Therapy
. 2019 May 24;13:1819. doi: 10.2147/DDDT.S215949

Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/Smad signaling pathway [Corrigendum]

Mao Mu, Shi Zuo, Rong-Min Wu, Kai-Sheng Deng, Shuang Lu, Juan-Juan Zhu, Gao-Liang Zou, Jing Yang, Ming-Liang Cheng, Xue-Ke Zhao
PMCID: PMC6538833  PMID: 31213770

Mu M, Zuo S, Wu RM, et al. Drug Des Devel Ther. 2018;12:4107–4115.

An error has been found in a couple of the image labels for Figure 3F. On page 4112, the original Figure 3F image appears as:

graphic file with name DDDT-13-1819-g0001.jpg

This should instead be replaced by:

graphic file with name DDDT-13-1819-g0002.jpg


Articles from Drug Design, Development and Therapy are provided here courtesy of Dove Press

RESOURCES